亚托皮性疾病和炎症性肠病:双向的门德尔随机化研究
Dongyuan Zheng1, Qinke Xu1, Yingchao Liu2
1The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Medicine
|October 21, 2024
概括
这项研究发现,过敏性鼻炎 (AR) 和喘因果上会增加炎症性肠病 (IBD) 的风险. 克罗恩病 (CD) 也被发现增加了AR的风险.
科学领域:
- 遗传学和流行病学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 观察性研究表明,亚托邦性疾病 (过敏性鼻炎,喘,亚托邦性皮肤炎) 和炎症性肠病 (IBD) 之间存在联系.
- 亚托皮性疾病和IBD之间的因果关系尚不清楚.
- 门德尔的随机化提供了一个强大的方法来研究使用遗传变异的因果关系.
研究的目的:
- 调查过敏性鼻炎 (AR),喘,皮炎 (AD) 和炎症性肠病 (IBD) 亚型 (克罗恩病 (CD) 和性结肠炎 (UC)) 之间的双向因果关系.
- 使用双样本门德尔随机化 (2SMR) 来评估因果关系的遗传证据.
- 要区分引起IBD的亚托皮性疾病和引起亚托皮性疾病的IBD.
主要方法:
- 汇集的全基因组关联研究 (GWAS) 数据被用于仪器变量选择.
- 进行了双样本孟德尔随机化 (2SMR) 分析,以评估双向因果关系.
- 工具变量根据三个核心的门德尔随机化假设进行了选.
主要成果:
- 过敏性鼻炎 (AR) 显著增加了CD,UC和整体IBD的风险.
- 喘显著增加了CD,UC和整体IBD的风险,与CD有特别强烈的关联.
- 亚托皮炎 (AD) 与CD和整体IBD风险增加有显著的关联.
- 反向因果关系分析表明,CD显著增加了AR的风险.
结论:
- 亚托皮性疾病,特别是AR和喘,与IBD及其亚型的发展有因果关系.
- 阿尔茨海默病也与IBD有因果关系,可能通过CD介导.
- 存在双向因果关系,CD增加了AR的风险,突出了这些条件之间的复杂相互作用.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
189
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
189
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
Inflammatory Bowel Disease IV: Pharmacological Management
117
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
117
Chronic Bowel Disorders: Introduction
394
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
394
Irritable Bowel Syndrome I: Introduction
252
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
252


